Eddie Lampert keeps selling AutoNation's stock: He has unloaded $55 million worth of shares this year.
By Tomi Kilgore
Lampert is still the car retailer's second-largest shareholder, with an 11% stake
Billionaire investor Eddie Lampert keeps cutting down his holdings of AutoNation Inc., having sold more than $55 million worth of the car retailer's stock so far this year.
In a Form 4 filing with the U.S. Securities and Exchange Commission late Tuesday, Lampert disclosed that he sold 31,477 AutoNation (AN) shares on the open market on May 5, at a weighted average price of $133.4665.
Lampert still has a stake of 5.2 million shares in the company, or about 11.4% of the shares outstanding. That puts him behind only Bill Gates' Cascade Investments LLC, which holds 21% of the shares outstanding, according to AutoNation's proxy statement.
So far this year, Lampert has filed eight Form 4s that disclosed sales of AutoNation shares. In total, he has sold 396,277 shares in 2023 at a weighted average price of $139.0074, according to a MarketWatch calculation, for total proceeds of $55.09 million.
The stock slumped 1.5% to $133.10, or about 4.2% below where Lampert sold his stock. The stock has soared 24.0% year to date, while the S&P 500 has gained 7.8%.
Lampert also filed a Form 4 on Jan. 4, in which he disclosed a sale of 99,380 AutoNation shares at $107.295 on Dec. 30, for proceeds of $10.66 million.
Lampert was a member of AutoNation's board for five years, until May 2007. He became famous for buying Sears and merging it with Kmart, then profiting even as he led the iconic retailer into bankruptcy, in which it remained mired in for years.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-11-23 0807ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth